tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
PremiumThe FlyXoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
25d ago
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
Premium
Ratings
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
1M ago
Generation Bio price target lowered to $5.50 from $7 at Wedbush
Premium
The Fly
Generation Bio price target lowered to $5.50 from $7 at Wedbush
1M ago
Xoma price target lowered to $97 from $104 at H.C. Wainwright
PremiumThe FlyXoma price target lowered to $97 from $104 at H.C. Wainwright
1M ago
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
Premium
Ratings
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
1M ago
Xoma price target lowered to $45 from $58 at Leerink
Premium
The Fly
Xoma price target lowered to $45 from $58 at Leerink
1M ago
Xoma announces closing of transaction to acquire Mural Oncology
PremiumThe FlyXoma announces closing of transaction to acquire Mural Oncology
2M ago
Mural Oncology announces effectiveness of scheme of arrangement
Premium
The Fly
Mural Oncology announces effectiveness of scheme of arrangement
2M ago
Mural Oncology announces final cash consideration payable on acquisition close
Premium
The Fly
Mural Oncology announces final cash consideration payable on acquisition close
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100